SECreport
Form 4 Celcuity Inc. For: May 14 Filed by: NIGON RICHARD

US:NASDAQ Investor Relations: celcuity.com/home/investors
IMPACT SNAPSHOT | EVENT TIME: | CELC | ||||
---|---|---|---|---|---|---|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
LAST PRICE | ||
VWAP | ||
High:
|
MAX UP |
High:
|
Low:
|
MAX DOWN |
Low:
|
%
|
POST NEWS RANGE |
%
|
|
PRICE CHANGE |
|
|
PRICE CHANGE PERCENTAGE |
|
|
S&P 500 (SPX) |
|
%
|
VOLUME RATIO |
%
|
VOLUME (SHARES) | ||
TICKS | ||
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
CELC alerts
CELC alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CELC alerts
High impacting Celcuity, Inc news events
Weekly update
A roundup of the hottest topics
CELC
NEWS
NEWS
- Celcuity Inc. Schedules Release of Fourth Quarter and Fiscal Year 2018 Financial Results and Conference Call[Business Wire]
- Celcuity Inc (NASDAQ: CELC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $36.00 price target on the stock.[MarketBeat]
- Celcuity Presents Results from Three Studies at the 2018 San Antonio Breast Cancer Symposium Evaluating HER2-Negative Breast Cancer Tumors with Hyperactive and Co-Activated HER Family and c-Met Signaling[Business Wire]
- Celcuity Inc (NASDAQ: CELC) was given a new $36.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.[MarketBeat]
- Celcuity Inc (NASDAQ: CELC) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.[MarketBeat]
- More